Pages that link to "Q39290981"
Jump to navigation
Jump to search
The following pages link to Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma (Q39290981):
Displaying 50 items.
- Cancer genome landscapes (Q22242276) (← links)
- NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes (Q24596715) (← links)
- Cancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesis (Q26766386) (← links)
- The mutational landscape of hepatocellular carcinoma (Q26777478) (← links)
- Biological features and biomarkers in hepatocellular carcinoma (Q26799462) (← links)
- Epigenetics in liver disease (Q26849263) (← links)
- Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience (Q26998606) (← links)
- SWI/SNF chromatin remodeling complexes and cancer (Q26998657) (← links)
- Emerging patterns of somatic mutations in cancer (Q27014126) (← links)
- Integrated molecular analysis of clear-cell renal cell carcinoma (Q27852382) (← links)
- Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016 (Q28072595) (← links)
- Genetic alterations in hepatocellular carcinoma: An update (Q28073241) (← links)
- Function and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver Disease (Q28073703) (← links)
- Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes (Q28271584) (← links)
- ARID1A mutations in cancer: another epigenetic tumor suppressor? (Q28280605) (← links)
- The SWI/SNF genetic blockade: effects in cell differentiation, cancer and developmental diseases (Q28292392) (← links)
- Biomarkers of genome instability and cancer epigenetics. (Q30248745) (← links)
- Possible Risk Factors of Pulmonary Metastases in Patients With International Federation of Gynecology and Obstetrics Stage I Endometrioid-Type Endometrial Cancer (Q30491534) (← links)
- Impact of the next-generation sequencing data depth on various biological result inferences (Q30587393) (← links)
- Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma (Q30834745) (← links)
- A bridge between multi-omics data and the management of hepatocellular carcinoma (Q30897690) (← links)
- Data on affected cancer-related genes in pediatric t(12;21)-positive acute lymphoblastic leukemia patients harboring unbalanced der(6)t(X;6) translocations (Q31120836) (← links)
- Mutations acquired by hepatocellular carcinoma recurrence give rise to an aggressive phenotype (Q33618512) (← links)
- Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis (Q33688583) (← links)
- Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma (Q33706203) (← links)
- A potentially functional variant of ARID1B interacts with physical activity in association with risk of hepatocellular carcinoma (Q33761625) (← links)
- CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice (Q33765935) (← links)
- Hepatocarcinogenesis associated with hepatitis B, delta and C viruses (Q33899640) (← links)
- Cyclin-dependent kinases (Q33900533) (← links)
- Identification of drivers from cancer genome diversity in hepatocellular carcinoma (Q33907993) (← links)
- Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma (Q33968053) (← links)
- SAMD9L inactivation promotes cell proliferation via facilitating G1-S transition in hepatitis B virus-associated hepatocellular carcinoma (Q33970149) (← links)
- Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition (Q34221658) (← links)
- Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma (Q34485283) (← links)
- CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice (Q34499647) (← links)
- Differences in somatic mutation landscape of hepatocellular carcinoma in Asian American and European American populations (Q34529055) (← links)
- Correlation between vertical transmission of hepatitis B virus and the expression of HBsAg in ovarian follicles and placenta (Q34575375) (← links)
- Integrated analyses of DNA methylation and hydroxymethylation reveal tumor suppressive roles of ECM1, ATF5, and EOMES in human hepatocellular carcinoma (Q34620256) (← links)
- Genomic analysis of fibrolamellar hepatocellular carcinoma (Q34673400) (← links)
- Revising a personal genome by comparing and combining data from two different sequencing platforms (Q34673480) (← links)
- ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors. (Q34708383) (← links)
- Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma. (Q34734133) (← links)
- Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers (Q34744054) (← links)
- Viral carcinogenesis: factors inducing DNA damage and virus integration (Q34774880) (← links)
- Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinoma (Q35029955) (← links)
- Genomic aberrations in the HTPAP promoter affect tumor metastasis and clinical prognosis of hepatocellular carcinoma (Q35112679) (← links)
- Protein domain-level landscape of cancer-type-specific somatic mutations (Q35203134) (← links)
- Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma (Q35611332) (← links)
- Altered expression of AT-rich interactive domain 1A in hepatocellular carcinoma. (Q35632160) (← links)
- Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma (Q35632953) (← links)